The U.S. Centers for Disease Control and Prevention (CDC) recommended shortening the interval between the second dose of Pfizer-BioNTech’s COVID-19 vaccine and the booster dose from six to five months.
The move comes after the U.S. Food and Drug Administration (FDA) decided on Monday to reduce the booster dose interval and authorize the use of a third dose of the Pfizer-BioNTech vaccine for children ages 12 to 12. 15 years.
The CDC has also recommended that moderately or severely immunosuppressed children ages 5 to 11 receive an additional dose of the vaccine 28 days after their second injection.
The Pfizer-BioNTech vaccine, cleared by the FDA in late October last year, is the only vaccine available to children ages 5 to 11 in the United States.
The CDC has not changed the recommendation of the booster interval for people who have received the Johnson & Johnson (J&J) or Moderna vaccine, which is still two and six months respectively.
.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
